Biomarkers for lupus nephritis: A critical appraisal

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Mok, Chi Chiu ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; AUTOANTIBODY; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C1Q ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; HEPCIDIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NUCLEOSOME ANTIBODY; PROTEOME; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; CLINICAL INDICATOR; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE MARKER; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BLOOD; LONGITUDINAL STUDY; METABOLISM; URINE;

ANIMALS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; HUMANS; LONGITUDINAL STUDIES; LUPUS NEPHRITIS;

EID: 77952529762     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/638413     Document Type: Review

References (98)

1. Mok C. C., Tang S. S. K., To C. H., Petri M., Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups Arthritis and Rheumatism 2005 52 9 2774 2782
2. Mok C. C., Tang S. S. K., Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus American Journal of Medicine 2004 117 10 791 795
3. Mok C. C., Prognostic factors in lupus nephritis Lupus 2005 14 1 39 44
4. Dooley M. A., Hogan S., Jennette C., Falk R., Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans Kidney International 1997 51 4 1188 1195
5. Mok C. C., Therapeutic options for resistant Lupus nephritis Seminars in Arthritis and Rheumatism 2006 36 2 71 81
6. Mok C. C., Update on emerging drug therapies for systemic lupus erythematosus Expert Opinion on Emerging Drugs 2010 15 53 70
7. Rovin B. H., Birmingham D. J., Nagaraja H. N., Yu C. Y., Hebert L. A., Biomarker discovery in human SLE nephritis Bulletin of the NYU Hospital for Joint Diseases 2007 65 3 187 193
8. Tesch G. H., Maifert S., Schwarting A., Rollins B. J., Kelley V. R., Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice Journal of Experimental Medicine 1999 190 12 1813 1824
9. Hasegawa H., Kohno M., Sasaki Miho, Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice Arthritis and Rheumatism 2003 48 9 2555 2566
10. Wada T., Segawa C., Su S. B., Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis Kidney International 1996 49 3 761 767
11. Rovin B. H., Doe N., Tan L. C., Monocyte chemoattractant protein-1 levels in patients with glomerular disease American Journal of Kidney Diseases 1996 27 5 640 646
12. Noris M., Bernasconi S., Casiraghi F., Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis Laboratory Investigation 1995 73 6 804 809
13. Kiani A. N., Johnson K., Chen C., Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis Journal of Rheumatology 2009 36 10 2224 2230
14. Rovin B. H., Song H., Birmingham D. J., Hebert L. A., Yu C. Y., Nagaraja H. N., Urine chemokines as biomarkers of human systemic lupus erythematosus activity Journal of the American Society of Nephrology 2005 16 2 467 473 (Pubitemid 41725143)
15. Tucci M., Barnes E. V., Sobel E. S., Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis Arthritis and Rheumatism 2004 50 6 1842 1849
16. Tian S., Wang Y., Jia J., Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare Inflammation Research 2007 56 7 304 310
17. Chan R. W. Y., Lai F. M. M., Li E. K. M., The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis Nephrology Dialysis Transplantation 2006 21 6 1534 1540
18. Schwartz N., Michaelson J. S., Putterman C., Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis Annals of the New York Academy of Sciences 2007 1109 265 274 (Pubitemid 47511369)
19. Mishra J., Qing M. A., Prada A., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury Journal of the American Society of Nephrology 2003 14 10 2534 2543
20. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., Devarajan P., Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity American Journal of Nephrology 2004 24 3 307 315
21. Trachtman H., Christen E., Cnaan A., Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury Pediatric Nephrology 2006 21 7 989 994
22. Rubinstein T., Pitashny M., Putterman C., The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis Autoimmunity Reviews 2008 7 3 229 234
23. Mishra J., Dent C., Tarabishi R., Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery The Lancet 2005 365 9466 1231 1238
24. Bolignano D., Lacquaniti A., Coppolino G., Campo S., Arena A., Buemi M., Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease Kidney and Blood Pressure Research 2008 31 4 255 258
25. Bolignano D., Donato V., Coppolino G., Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage American Journal of Kidney Diseases 2008 52 3 595 605
26. Qing X., Zavadil J., Crosby M. B., Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells Arthritis and Rheumatism 2006 54 7 2198 2210
27. Brunner H. I., Mueller M., Rutherford C., Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus Arthritis and Rheumatism 2006 54 8 2577 2584
28. Pitashny M., Schwartz N., Qing X., Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis Arthritis and Rheumatism 2007 56 6 1894 1903
29. Suzuki M., Wiers K. M., Klein-Gitelman M. S., Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis Pediatric Nephrology 2008 23 3 403 412
30. Hinze C. H., Suzuki M., Klein-Gitelman M., Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity Arthritis and Rheumatism 2009 60 9 2772 2781
31. Rubinstein T., Pitashny M., Levine B., Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology. In press
32. Ortiz A., Sanz A. B., Garca B. M., Considering TWEAK as a target for therapy in renal and vascular injury Cytokine and Growth Factor Reviews 2009 20 3 251 258
33. Winkles J. A., The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Nature Reviews Drug Discovery 2008 7 5 411 425
34. Campbell S., Putterman C. L., Gao H. X., Proinflammatory effects of Tweak/Fn14 interactions in glomerular mesangial cells Journal of Immunology 2006 176 3 1889 1898
35. Gao H. X., Campbell S. R., Burkly L. C., TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells Cytokine 2009 46 1 24 35
36. Gaipl U. S., Voll R. E., Sheriff A., Franz S., Kalden J. R., Herrmann M., Impaired clearance of dying cells in systemic lupus erythematosus Autoimmunity Reviews 2005 4 4 189 194 (Pubitemid 40704701)
37. Kaplan M. J., Lewis E. E., Shelden E. A., The apoptotic ligands TRAIL, TWEAK, and fas ligand mediate monocyte death induced by autologous lupus T cells Journal of Immunology 2002 169 10 6020 6029
38. Schwartz N., Su L., Burkly L. C., Urinary TWEAK and the activity of lupus nephritis Journal of Autoimmunity 2006 27 4 242 250
39. Schwartz N., Rubinstein T., Burkly L. C., Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study Arthritis Research Therapy 2009 11 5 R143
40. Suzuki M., Ross G. F., Wiers K., Identification of a urinary proteomic signature for lupus nephritis in children Pediatric Nephrology 2007 22 12 2047 2057
41. Mosley K., Tam F. W., Edwards R. J., Crozier J., Pusey C. D., Lightstone L., Urinary proteomic profiles distinguish between active and inactive lupus nephritis Rheumatology 2006 45 12 1497 1504
42. Suzuki M., Wiers K., Brooks E. B., Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis Pediatric Research 2009 65 5 530 536
43. Malyszko J., Mysliwiec M., Hepcidin in anemia and inflammation in chronic kidney disease Kidney and Blood Pressure Research 2007 30 1 15 30
44. Nemeth E., Valore E. V., Territo M., Schiller G., Lichtenstein A., Ganz T., Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 2003 101 7 2461 2463
45. Lee P., Peng H., Gelbart T., Wang L., Beutler E., Regulation of hepcidin transcription by interleukin-1 and interleukin-6 Proceedings of the National Academy of Sciences of the United States of America 2005 102 6 1906 1910
46. Zhang X., Jin M., Wu H., Biomarkers of lupus nephritis determined by serial urine proteomics Kidney International 2008 74 6 799 807
47. Tsirogianni A., Pipi E., Soufleros K., Relevance of anti-C1q autoantibodies to lupus nephritis Annals of the New York Academy of Sciences 2009 1173 243 251
48. Trendelenburg M., Antibodies against C1q in patients with systemic lupus erythematosus Springer Seminars in Immunopathology 2005 27 3 276 285
49. Seelen M. A., Trouw L. A., Daha M. R., Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus Current Opinion in Nephrology and Hypertension 2003 12 6 619 624
50. Jesus A. J., Silva C. A., Carneiro-Sampaio M., Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus Annals of the New York Academy of Sciences 2009 1173 235 238
51. Siegert C. E. H., Daha M. R., Tseng C. M. E. S., Coremans I. E. M., van Es L. A., Breedveld F. C., Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus Annals of the Rheumatic Diseases 1993 52 12 851 856
52. Moura C. G., Lima I., Barbosa L., Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus Journal of Clinical Laboratory Analysis 2009 23 1 19 23
53. Fang Q. Y., Yu F., Tan Y., Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis Nephrology Dialysis Transplantation 2009 24 1 172 178
54. Sinico R. A., Radice A., Ikehata M., Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance Annals of the New York Academy of Sciences 2005 1050 193 200
55. Wu F. Q., Zhao Q., Cui X. D., Zhang W., C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatology International. In press
56. Mosca M., Chimenti D., Pratesi F., Prevalence and clinico-serological correlations of anti--enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus Journal of Rheumatology 2006 33 4 695 697
57. Hork P., Hermanov Z., Zadrazil J., C1q complement component and antibodies reflect SLE activity and kidney involvement Clinical Rheumatology 2006 25 4 532 536
58. Moroni G., Trendelenburg M., Del Papa N., Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis American Journal of Kidney Diseases 2001 37 3 490 498
59. Trendelenburg M., Lopez-Trascasa M., Potlukova E., High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis Nephrology Dialysis Transplantation 2006 21 11 3115 3121
60. Sinico R. A., Rimoldi L., Radice A., Bianchi L., Gallelli B., Moroni G., Anti-C1q autoantibodies in lupus nephritis Annals of the New York Academy of Sciences 2009 1173 47 51
61. Meyer O. C., Nicaise-Roland P., Cadoudal N., Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus Arthritis Research and Therapy 2009 11 3, article R87
62. Moroni G., Radice A., Giammarresi G., Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis Annals of the Rheumatic Diseases 2009 68 2 234 237
63. Hoftman A. D. C., Tai L. Q., Tze S., Seligson D., Gatti R. A., McCurdy D. K., MAGE-B2 autoantibody: a new biomarker for pediatric systemic lupus erythematosus Journal of Rheumatology 2008 35 12 2430 2438
64. Tan Y., Yu F., Yang H., Chen M., Fang Qiying, Zhao M. H., Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions Human Immunology 2008 69 12 840 844
65. Tucci M., Lombardi L., Richards H. B., Dammacco F., Silvestris F., Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis Clinical and Experimental Immunology 2008 154 2 247 254
66. Fu Q., Chen X., Cui H., Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients Arthritis Research and Therapy 2008 10 5, article R112
67. Morgan P. E., Sturgess A. D., Hennessy A., Davies M. J., Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis Free Radical Research 2007 41 12 1301 1312
68. Sabry A., Sheashaa H., El-Husseini A., El-Dahshan K., Abdel-Rahim M., Elbasyouni S. R., Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis Clinical Rheumatology 2007 26 11 1819 1823
69. Tseng J. C., Lu L. Y., Hu R. J., Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus Journal of Microbiology, Immunology and Infection 2007 40 1 50 55
70. Bruns A., Blss S., Hausdorf G., Burmester G. R., Hiepe F., Nucleosomes are major T and B cell autoantigens in systemic Lupus erythematosus Arthritis and Rheumatism 2000 43 10 2307 2315
71. Koutouzov S., Jeronimo A. L., Campos H., Amoura Z., Nucleosomes in the pathogenesis of systemic lupus erythematosus Rheumatic Disease Clinics of North America 2004 30 3 529 558
72. Kalaaji M., Fenton K. A., Mortensen E. S., Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis Kidney International 2007 71 7 664 672
73. Wang G., Lai F. M.-M., Tam L.-S., Urinary FOXP3 mRNA in patients with lupus nephritisrelation with disease activity and treatment response Rheumatology 2009 48 7 755 760
74. Dhaun N., Lilitkarntakul P., MacIntyre I. M., Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis American Journal of Physiology 2009 296 6 F1477 F1483
75. + T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients Arthritis and Rheumatism 2009 60 1 199 206
76. Wu T., Xie C., Wang H. W., Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis Journal of Immunology 2007 179 10 7166 7175
77. Hammad A. M., Youssef H. M., El-Arman M. M., Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis Lupus 2006 15 9 608 612
78. Chan R. W. Y., Lai F. M. M., Li E. K. M., Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis Arthritis and Rheumatism 2004 50 9 2882 2890
79. Gmez-Puerta J. A., Burlingame R. W., Cervera R., Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value Autoimmunity Reviews 2008 7 8 606 611
80. Cervera R., Vias O., Ramos-Casals M., Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy Annals of the Rheumatic Diseases 2003 62 5 431 434
81. Amoura Z., Koutouzov S., Chabre H., Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus Arthritis and Rheumatism 2000 43 1 76 84
82. Grootscholten C., Dieker J. W. C., McGrath F. D., A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/ methylprednisolone Annals of the Rheumatic Diseases 2007 66 5 693 696 (Pubitemid 46707143)
83. Oates J. C., Shaftman S. R., Self S. E., Gilkeson G. S., Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis Arthritis and Rheumatism 2008 58 1 263 272
84. Marks S. D., Williams S. J., Tullus K., Sebire N. J., Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in paediatric lupus nephritis Nephrology Dialysis Transplantation 2008 23 11 3521 3526
85. Nakayamada S., Saito K., Nakano K., Tanaka Y., Activation signal transduction by 1 integrin in T cells from patients with systemic lupus erythematosus Arthritis and Rheumatism 2007 56 5 1559 1568
86. Avihingsanon Y., Phumesin P., Benjachat T., Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis Kidney International 2006 69 4 747 753
87. do Nascimento A. P., Viana V. D. S. T., Testagrossa L. D. A., Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis Arthritis and Rheumatism 2006 54 5 1568 1572
88. Oates J. C., Varghese S., Bland A. M., Prediction of urinary protein markers in lupus nephritis Kidney International 2005 68 6 2588 2592
89. Izmirly P. M., Barisoni L., Buyon J. P., Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis Rheumatology 2009 48 5 513 519
90. Avihingsanon Y., Benjachat T., Tassanarong A., Sodsai P., Kittikovit V., Hirankarn N., Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis Kidney International 2009 75 12 1340 1348
91. Martinez-Lostao L., Ordi-Ros J., Balada E., Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis Lupus 2007 16 7 483 488
92. Manson J. J., Ma A., Rogers P., Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study Arthritis Research Therapy 2009 11 5 R154
93. Renaudineau Y., Deocharan B., Jousse S., Renaudineau E., Putterman C., Youinou P., Anti-alpha-actinin antibodies: a new marker of lupus nephritis Autoimmunity Reviews 2007 6 7 464 468
94. Deocharan B., Qing X., Lichauco J., Putterman C., actinin is a cross-reactive renal target for pathogenic anti-DNA aptibodies Journal of Immunology 2002 168 6 3072 3078
95. Zhao Z., Weinstein E., Tuzova M., Cross-reactivity of human lupus anti-DNA antibodies with-actinin and nephritogenic potential Arthritis and Rheumatism 2005 52 2 522 530
96. Mason L. J., Ravirajan C. T., Rahman A., Putterman C., Isenberg D. A., Is-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis and Rheumatism 2004 50 3 866 870
97. Renaudineau Y., Croquefer S., Jousse S., Association of-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis Arthritis and Rheumatism 2006 54 8 2523 2532
98. Becker-Merok A., Kalaaji M., Haugbro K., actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis Arthritis Research and Therapy 2006 8 6, article R162